| Year | Title | Author(s) |
| 2016 |
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common beta chain of the IL-3, GM-CSF and IL-5 receptors
Mabs |
Panousis, C Dhagat, U Edwards, KM Rayzman, V Hardy, MP Braley, H Gauvreau, GM Hercus, TR Smith, S Sehmi, R McMillan, L Dottore, M McClure, BJ Fabri, LJ Vairo, G Lopez, AF Parker, MW Nash, AD Wilson, NJ Wilson, MJ Owczarek, CM |
| 2014 |
Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody.
Cell Rep |
Parker, MW Hercus, TR Hardy, MP Broughton, SE McClure, BJ Dottore, M Huynh, H Braley, H Barry, EF Kan, WL Dhagat, U Scotney, PD Hartman, D Busfield, SJ Owczarek, CM Nash, AD Wilson, NJ Lopez, AF |